WCLC 2021: Epidemiology of MET Exon 14 mutations

Cancer Health Disparities Special Issue - Editorial

ESMO 2021: PARPi data and their role in mono/combination therapies

Radioembolisation with chemotherapy for colorectal liver metastases

Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve efficacy in ovarian, fallopian, peritoneal cancer

Drug combination shows promise in treatment-resistant advanced ovarian cancer

Welcome to APCCC 2021

ESMO 2021 Roundup

New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma

PARP inhibitors in prostate cancer: Case based testing and clinical decisions

Erdafitinib (ERDA) or ERDA plus cetrelimab for patients with metastatic or locally advanced urothelial carcinoma (mUC) and FGFRa